|
|
|
|
A gene expression signature clearly distinguishes
Burkitt lymphoma from DLBCL, a critical distinction
in diagnosis. |
|
Dr. Tamer Fouad, M.D.
|
|
Monday 12th June, 2006 |
|
|
|
|
Breast cancer with a certain genetic mutation can
have breast-sparing surgery but should consider
hormonal treatments. |
|
Dr. Tamer Fouad, M.D.
|
|
Friday 9th June, 2006 |
|
|
|
|
A new test could give hospitals with limited resources an
affordable way to improve the outcome of ALL treatment. |
|
Dr. Tamer Fouad, M.D.
|
|
Friday 31st March, 2006 |
|
|
|
|
This trial is among the first to combine a biologic agent with
a conventional chemotherapy agent for ovarian cancer. |
|
Dr. Tamer Fouad, M.D.
|
|
Sunday 26th March, 2006 |
|
|
|
|
Inability to repair chromosomal damage caused by UV-B radiation increases
risk of basal cell and squamous cell carcinomas.
|
|
Dr. Tamer Fouad, M.D.
|
Monday 16th January, 2006
|
|
|
|
|
A study featured in Gynecologic Oncology shows the superiority of
intraperitoneal chemotherapy in advanced ovarian cancer.
|
|
Dr. Tamer Fouad, M.D.
|
Wednesday 11th January, 2006
|
|
|
|
|
Women with genetic variant that are taking tamoxifen were more likely to see
their cancer return.
|
|
Dr. Tamer Fouad, M.D.
|
Saturday 17th December, 2005
|
|
|
|
|
NEJM reports that Herceptin® following standard chemotherapy significantly
reduces the risk of disease recurrence.
|
|
Dr. Tamer Fouad, M.D.
|
Monday 24th October, 2005
|
|
|
|
|
The FDA has approved Pfizer's Aromasin® for adjuvant treatment of early
breast cancer in postmenopausal women.
|
|
Dr. Tamer Fouad, M.D.
|
Wednesday 12th October, 2005
|
|
|
|
|
GARDASIL, an investigational vaccine shows promise in preventing cervical
cancer associated with HPV infections.
|
|
Dr. Tamer Fouad, M.D.
|
|
|
|
|
|
|
A Mayo Clinic study shows women with benign breast disease have a higher risk
for breast cancer.
|
|
Dr. Tamer Fouad, M.D.
|
|
|
|
|
|
|
Study demonstrates that a drug called erlotinib (Tarceva)
increases survival in patients with advanced non-small cell lung cancer.
|
|
Dr. Tamer Fouad, M.D.
|
|
|
|
|
|
|
SV40 does not have a role in the majority of malignant mesotheliomas
according to a study in this month's Cancer Research.
|
|
Dr. Tamer Fouad,
M.D.
|
|
|
|
|
|
|
FDA has granted full approval to DOXIL® for the treatment of ovarian cancer
that has progressed or recurred after platinum-based chemotherapy.
|
|
Dr. Tamer Fouad,
M.D.
|
Monday 21st February, 2005
|
|
|
|
|
Interactions between certain genetic polymorphisms and
antidepressants (SSRIs) may be associated with altered tamoxifen activity.
|
|
Dr. Tamer Fouad,
M.D.
|
Friday, 21st January 2005
|
|
|
|
|
A large clinical trial comparing Iressa (gefitinib) with placebo in patients
with non-small cell lung cancer showed no survival benefit from taking Iressa.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Wednesday,
22nd December 2004 |
|
|
|
|
The results suggest that almost half of those diagnosed with
estrogen-dependent, lymph-node negative breast cancer may not need chemotherapy.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Sunday,
12th December 2004 |
|
|
|
|
The results suggest that those receiving more intense therapies are
associated with a longer disease free survival than those receiving lower-dose
therapies.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Monday,
28th November 2004 |
|
|
|
|
The results clearly indicate the efficacy of cord blood stem cells when bone
marrow donors are unavailable for high risk patients.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Monday,
22nd November 2004 |
|
|
|
|
Investigators found no increase in the risk of cancer recurrence in young
women with mutations that were treated with conservative surgery.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Monday,
22nd November 2004 |
|
|
|
|
In those women who completed the protocol the vaccine was 100 percent
effective against persistent HPV16/18 infections.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Friday,
12th November 2004 |
|
|
|
|
Celecoxib treatment appears to exert its antiproliferative, antiangiogenic,
and pro-apoptotic effects on cancer by regulating the prostaglandin pathways.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Wednesday, 11th November
2004 |
|
|
|
|
There had previously been no approved therapies for
MDS. Vidaza
is the first FDA approved drug for MDS.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Monday, 8th June 2004 |
|
|
|
|
Patients who underwent routine follow up with the tumor marker
and CT scan enjoyed a longer survival.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Monday, 3rd May 2004 |
|
|
|
|
X-rays have been the cause of more than 5,600 cancer cases in the United
States according to the study.
|
|
Dr. Tamer Fouad,
M.D.
|
|
Saturday,
12th January 2004 |
|
|
|
|
Gefitinib is the first oral drug approved in the United States for the
treatment of non-small cell lung cancer.
|
|
|
|
|
|
|
Telomerase adds nucleotides to the
ends of chromosomes to compensate for losses during DNA replication.
|
|
Dr. Tamer Fouad,
M.D.
|
|
|
|
|
Active oxygen species have long been known to be mutagenic,
hence playing a role in cancer formation.
|
send
to a friend
printer
friendly version
